Amedisys, Inc.

NasdaqGS:AMED 株式レポート

時価総額:US$3.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Amedisys マネジメント

マネジメント 基準チェック /14

Amedisys'の CEO はRichard Ashworthで、 Apr2023年に任命され、 の在任期間は 1.17年です。 の年間総報酬は$ 16.97Mで、 4.1%給与と95.9%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.088%を直接所有しており、その価値は$ 2.64M 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と4.6年です。

主要情報

Richard Ashworth

最高経営責任者

US$17.0m

報酬総額

CEO給与比率4.1%
CEO在任期間1.2yrs
CEOの所有権0.09%
経営陣の平均在職期間1.7yrs
取締役会の平均在任期間4.6yrs

経営陣の近況

Recent updates

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?

Apr 10
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?

Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?

Feb 25
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?

Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around

Feb 10
Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around

At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jan 03
At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Dec 16
A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Nov 12
Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

Sep 19
Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Sep 04
An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Amedisys: ROIC, Tangible Book Value Each Softening

Aug 24

Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Aug 04
Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates

Jul 27

We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

Jul 20
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jun 04
At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

May 05
Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Apr 20
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Apr 06
Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Is Amedisys (NASDAQ:AMED) A Risky Investment?

Feb 20
Is Amedisys (NASDAQ:AMED) A Risky Investment?

Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Dec 03
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Nov 18
These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Aug 18
Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Jul 23
Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity

Jul 18

Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

Jun 28
Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Jun 02
It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

May 24
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

CEO報酬分析

Amedisys の収益と比較して、Richard Ashworth の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$21m

Dec 31 2023US$17mUS$692k

-US$10m

報酬と市場: Richardの 総報酬 ($USD 16.97M ) は、 US市場 ($USD 6.83M ) の同規模の企業の平均を上回っています。

報酬と収益: Richardの報酬と会社の業績を比較するにはデータが不十分です。


CEO(最高経営責任者

Richard Ashworth (49 yo)

1.2yrs

在職期間

US$16,974,025

報酬

Mr. Richard M. Ashworth served as Director at Tivity Health, Inc. since June 1, 2020 until April 2023 and had been its President since June 1, 2020 and served as its Chief Executive Officer since June 1, 2...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Richard Ashworth
President1.2yrsUS$16.97m0.088%
$ 2.7m
Scott Ginn
Executive VP6.7yrsUS$4.45m0.067%
$ 2.0m
Michael North
Chief Information Officer7.6yrsUS$1.55m0.033%
$ 981.1k
Denise Bohnert
Chief Compliance Officer4.8yrsUS$1.28mデータなし
Nick Muscato
Chief Strategy Officerno dataUS$1.37m0.0061%
$ 183.3k
Allyson Guidroz
Chief Accounting Officer & Principal Accounting Officerless than a yearデータなし0.0050%
$ 150.2k
Pete Hartley
CTO & Senior VP of Business Operations Systemsno dataデータなしデータなし
Jennifer Griffin
Senior VP1.7yrsデータなしデータなし
Kendra Kimmons
VP of Marketing & Communications & Media Relationsno dataデータなしデータなし
Caitlin Franklin
Acting Chief People Officerno dataデータなしデータなし
Francis Mayer
Senior Vice President of Developmentno dataデータなしデータなし

1.7yrs

平均在職期間

49yo

平均年齢

経験豊富な経営陣: AMEDの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Richard Ashworth
President1.2yrsUS$16.97m0.088%
$ 2.7m
Paul Kusserow
Chairman9.5yrsUS$4.00m1.34%
$ 40.2m
Bruce Perkins
Independent Director9.2yrsUS$267.62k0.063%
$ 1.9m
Vickie Capps
Independent Director4.6yrsUS$277.62k0.020%
$ 594.3k
Molly Coye
Independent Director4.6yrsUS$267.62k0.017%
$ 502.2k
Julie Klapstein
Lead Independent DIrector8.2yrsUS$282.62k0.039%
$ 1.2m
Jeffrey Rideout
Independent Director8.2yrsUS$267.62k0.018%
$ 549.7k
Teresa Kline
Independent Director4.6yrsUS$272.62k0.020%
$ 594.3k
Ivanetta Samuels
Independent Director3.5yrsUS$252.62k0.013%
$ 389.9k

4.6yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: AMEDの 取締役会経験豊富 であると考えられます ( 4.6年の平均在任期間)。